The medical world is witnessing a significant shift in glucose treatment with the introduction of GLP-1 skin applications. These systems offer a possibly more convenient alternative to shots of GLP-1 receptor agonists, minimizing the requirement of daily needle pokes. The innovation releases the medication directly through the skin, possibly improv